Dr. Scott Shie

Dr. Scott Shie
Scott D. Shie, MD, earned his medical degree from the University of Cincinnati College of Medicine in Cincinnati, Ohio. He is board certified in Urology and has 15 years of surgical and urological experience from internship, residency, and practice in Ohio and Indiana. Dr. Shie is currently a member of the American Urological Association, the Ohio and Indiana Urological Societies, and several other state and local medical organizations. He has extensive service and experience on numerous medical committees ranging from pelvic health, surgical leadership, and quality boards. Dr. Shie has been published in the Journal of Endourology and given presentations for the American Urological Association. He has a special interest in helping patients who struggle with BPH, kidney stones, and incontinence. He was the first in the tri-state (Ohio, Indiana, Michigan) region to provide Aquablation therapy for BPH.

Languages Spoken:


Medical School:

University of Cincinnati College of Medicine


NEOUCOM (Northeast Ohio University College of Medicine - Akron General Medical Center/Akron City Hospital - Summa Health System/Akron Children's Hospital)


Denison University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only